RainDance Technologies Expands Thunderbolts Portfolio With Launch Of Low-Cost, Low-Input Next-Gen Sequencing Enrichment System For Liquid Biopsy

BILLERICA, Mass.--(BUSINESS WIRE)--RainDance Technologies, Inc., a genomics tools company dedicated to simplifying the analysis of complex genetic diseases, today announced the launch and availability of the ThunderBolts™ Next-Generation Sequencing (NGS) Target Enrichment System. The ThunderBolts System enables researchers to rapidly detect and cost-effectively analyze somatic mutations from liquid biopsy samples (circulating tumor DNA) or precious FFPE (formalin-fixed Paraffin-Embedded) tissue samples. RainDance recently showcased the new ThunderBolts System and performance data at the International Molecular Medicine Tri-Conference, and will highlight the ThunderBolts System at the upcoming Advances in Genome Biology and Technology Meeting.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC